NKGN
- NKGen Biotech, Inc.
()
Overview
Company Summary
NKGen Biotech, Inc. (NKGN) is a biotechnology company focused on advanced pharmaceutical research and development. The company specializes in harnessing the power of natural killer (NK) cells for therapeutic purposes.
NK cells are a type of white blood cell in the immune system that play a crucial role in fighting off cancer and viral infections. NKGen Biotech aims to harness the potential of these cells by developing innovative technologies and therapeutic solutions to combat various diseases.
The company focuses on two main areas: NK cell therapies and NK-based diagnostics. In the field of NK cell therapies, NKGen Biotech is engaged in developing novel and targeted immunotherapies that can boost the activity and effectiveness of NK cells in fighting cancer. These therapies involve engineering and enhancing NK cells to specifically target and destroy cancer cells.
NKGen Biotech also specializes in NK-based diagnostics, which involve the detection and monitoring of diseases using NK cells. By leveraging the unique properties of NK cells, the company develops diagnostic tools and assays to accurately identify different types of diseases, including cancer, and monitor the progression or response to treatment.
Overall, NKGen Biotech, Inc. is dedicated to unlocking the potential of NK cells for therapeutic purposes, aiming to revolutionize the field of immunotherapy by providing innovative solutions for the diagnosis, treatment, and management of various diseases, particularly cancer.